NCT06354491

Brief Summary

This study will validate recently developed Magnetic Resonance Imaging (MRI) and Ultrasound (US) based methods for liver fat quantification in children with obesity and healthy range of body mass index (BMI).

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
26mo left

Started Apr 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Apr 2024Jul 2028

Study Start

First participant enrolled

April 1, 2024

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 9, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2025

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2028

Expected
Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

1.2 years

First QC Date

April 3, 2024

Last Update Submit

December 15, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility Measured by the Number of Participants Who Successfully Complete the Interventions

    Demonstrate the feasibility of MRI- and US-based liver fat quantification in children and address technical challenges that may limit the performance of the proposed techniques in the population of interest.

    through study enrollment (up to approximately 14 months)

Secondary Outcomes (6)

  • MRI: Bias reported as difference in mean error in Percent Liver Fat measured from free-breathing MRI method and reference breath-held MRI method

    Research visit 1 (up to 14 months)

  • MRI: Precision measured by Test-Retest of Percent Liver Fat

    Research visit 1 (up to 14 months)

  • Quantitative US: Repeatability of US Measurements (same sonographer) - Attenuation Coefficient (dB/cm-MHz)

    Research visit 1 (up to 14 months)

  • Quantitative US: Repeatability of US Measurements (same sonographer) - Backscatter Coefficient (1/cm*sr)

    Research visit 1 (up to 14 months)

  • Quantitative US: Reproducibility of US Measurements (different sonographers) - Attenuation Coefficient (dB/cm-MHz)

    Research visit 1 (up to 14 months)

  • +1 more secondary outcomes

Study Arms (2)

Average or low BMI

EXPERIMENTAL

Children with BMI under the 85th percentile for age and sex

Device: Magnetic Resonance Imaging (MRI)Device: Ultrasound (US)

High BMI

EXPERIMENTAL

Children with BMI in the 95th percentile or higher for age and sex

Device: Magnetic Resonance Imaging (MRI)Device: Ultrasound (US)

Interventions

MRI procedures will include a 20-25 minute exam with periodic breath holds. The imaging series will be conducted twice to assess repeatability.

Average or low BMIHigh BMI

In each ultrasound exam, each participant will be scanned by twice by the same sonographer to evaluate intra-operator variability (repeatability). Each exam will take approximately 60 minutes to complete.

Average or low BMIHigh BMI

Eligibility Criteria

Age10 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Age: 10 - 14years old
  • BMI: Case subjects: BMI\>95th percentile for age and sex Healthy BMI volunteers: 5th ≤ BMI \< 85th percentile for age and sex

You may not qualify if:

  • Children with contraindications to MRI.
  • Children who did not fast (verbally confirmed by children or guardian)
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin, Madison

Madison, Wisconsin, 53705, United States

Location

MeSH Terms

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

Magnetic Resonance ImagingUltrasonography

Condition Hierarchy (Ancestors)

Fatty LiverLiver DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Ivan Rosado-Mendez, PhD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR
  • Diego Hernando, PhD

    University of Wisconsin, Madison

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2024

First Posted

April 9, 2024

Study Start

April 1, 2024

Primary Completion

June 20, 2025

Study Completion (Estimated)

July 1, 2028

Last Updated

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations